Federal solicitation · 75N93024R00022 · back to recent
Notice of Intent to Sole Source - Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NAICS 541714 · Deadline 2026-05-15T15:00:00-04:00
Solicitation description
The aim of this solicitation is to continue the Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB) responsible for coordinating and conducting the design, synthesis, in vitro testing, and distribution of chemical libraries of discrete natural products and small-molecules with diverse physicochemical properties, specifically designed to target Gram-negative bacterial pathogens and other antibiotic-resistant bacteria identified as Antimicrobial Resistance threats. The contract shall consist of requirements in four (4) key areas: 1) Library Design, 2) Compound Synthesis, 3) Compound Testing, and 4) Compound Management, and includes Project Management of all efforts across these requirements. Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on April 08, 2026, and may be accessed through https://sam.gov/. Please note: After opening/downloading the solicitation in the Chrome browser, click the down arrow and select "Open with system viewer" to view the RFP in Adobe Acrobat. This process will allow the links in Section J of the RFP to work properly. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. For this solicitation, the NIAID requires proposals to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) website. Submission of proposals by facsimile or e-mail is not acceptable. For directions on using eCPS, go to the website https://ecps.nih.gov/ and then click on "How to Submit."
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Strategic Marburg Advanced Research and Development,... | HEALTH AND HUMAN... | $1,042.1M | same agency naics |
| Biomedical Advanced Research and Development Authority... | HEALTH AND HUMAN... | $99.7M | same agency naics |
| R & D to develop Execabase to combat S. aureus | HEALTH AND HUMAN... | $86.8M | same agency naics |
| BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003) | HEALTH AND HUMAN... | $7.5M | same agency naics |
| Toxicity of Resin 3-D Printing Emissions: Phase 1 | HEALTH AND HUMAN... | - | same agency naics |
| BIOmolecular Grammar for protein Aggregation Modulation... | HEALTH AND HUMAN... | - | same agency naics |
| Notice of Intent to issue a Sole Source Award for... | HEALTH AND HUMAN... | - | same agency naics |
| AI-Enabled Discovery of Broad-Spectrum Small-Molecule... | HEALTH AND HUMAN... | - | same agency naics |
Data this profile does NOT cover
- No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.
- No FPDSAward rows for NAICS 541714 in the trailing 12 months; vendor concentration unavailable.